Latest Breaking News On - Italfarmaco paolo bettica - Page 1 : comparemela.com

Givinostat, a histone deacetylase inhibitor from Italfarmaco, was supported by data from the phase 3 EPIDYS study, a randomized, double-blind, placebo-controlled, multicenter trial investigating the agent vs placebo.

Paolo betticaItalfarmaco paolo betticaCraig mcdonaldDepartment of pediatricsUc davis healthUc davis health craig mcdonaldPrescription drug user fee actNorth star ambulatory assessmentPhysical medicineHistone deacetylase